These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2561683)

  • 41. Platelet 3H-imipramine binding: a state-dependent marker in depression.
    Suranyi-Cadotte B; Quirion R; McQuade P; Nair NP; Schwartz G; Mosticyan S; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):737-41. PubMed ID: 6531445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet 3H-imipramine binding in bipolar patients.
    Muscettola G; Di Lauro A; Giannini CP
    Psychiatry Res; 1986 Aug; 18(4):343-53. PubMed ID: 3018819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
    Kim SW; Dysken MW; Pandey GN; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 45. Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
    Severson JA; Schneider LS; Fredrickson ER
    Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study.
    Pharmacopsychiatry; 1990 May; 23(3):113-7. PubMed ID: 2165264
    [No Abstract]   [Full Text] [Related]  

  • 47. Platelet 3H-imipramine binding in psychogenic pain patients.
    Mellerup ET; Bech P; Hansen HJ; Langemark M; Loldrup D; Plenge P
    Psychiatry Res; 1988 Nov; 26(2):149-56. PubMed ID: 2853399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imipramine binding in depression and other psychiatric conditions.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand Suppl; 1988; 345():61-8. PubMed ID: 2852451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression: an exploratory study of clinical heterogeneity.
    Carr V; Edwards J; Prior M
    Biol Psychiatry; 1988 Mar; 23(6):560-74. PubMed ID: 2833320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet 3H-imipramine binding in euthymic bipolar patients.
    Berrettini WH; Nurnberger JI; Post RM; Gershon ES
    Psychiatry Res; 1982 Oct; 7(2):215-9. PubMed ID: 6959171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta-adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders.
    Jeanningros R; Mazzola P; Azorin JM; Samuelian-Massa C; Tissot R
    Biol Psychiatry; 1991 Apr; 29(8):789-98. PubMed ID: 1675894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased platelet 3H-imipramine binding in Down's syndrome.
    Tang SW; Berg JM; Bruni J; Davis A
    Psychiatry Res; 1988 Apr; 24(1):67-70. PubMed ID: 2839861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 56. [Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs].
    Katasonov AB; Beliaev BS; Zlobina GP; Faktor MI; Brusov OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):125-8. PubMed ID: 2728713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
    Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
    Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imipramine binding sites in brain and platelets: role in affective disorders.
    Hrdina PD
    Int J Clin Pharmacol Res; 1989; 9(2):119-22. PubMed ID: 2541089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy.
    Maj M; Mastronardi P; Cerreta A; Romano M; Mazzarella B; Kemali D
    Biol Psychiatry; 1988 Aug; 24(4):469-72. PubMed ID: 2841987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.